407 related articles for article (PubMed ID: 17186219)
1. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of MODY2 mutations in the nuclear export signal of glucokinase.
Gutierrez-Nogués A; García-Herrero CM; Oriola J; Vincent O; Navas MA
Biochim Biophys Acta Mol Basis Dis; 2018 Jul; 1864(7):2385-2394. PubMed ID: 29704611
[TBL] [Abstract][Full Text] [Related]
3. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
4. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.
Liu L; Liu Y; Ge X; Liu X; Chen C; Wang Y; Li M; Yin J; Zhang J; Chen Y; Zhang R; Jiang Y; Zhao W; Yang D; Zheng T; Lu M; Zhuang L; Jiang M
Metabolism; 2018 Dec; 89():8-17. PubMed ID: 30257192
[TBL] [Abstract][Full Text] [Related]
5. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.
Galán M; Vincent O; Roncero I; Azriel S; Boix-Pallares P; Delgado-Alvarez E; Díaz-Cadórniga F; Blázquez E; Navas MA
Biochem J; 2006 Jan; 393(Pt 1):389-96. PubMed ID: 16173921
[TBL] [Abstract][Full Text] [Related]
6. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
[TBL] [Abstract][Full Text] [Related]
7. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
[TBL] [Abstract][Full Text] [Related]
8. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.
Rees MG; Wincovitch S; Schultz J; Waterstradt R; Beer NL; Baltrusch S; Collins FS; Gloyn AL
Diabetologia; 2012 Jan; 55(1):114-22. PubMed ID: 22038520
[TBL] [Abstract][Full Text] [Related]
9. Characterization of glucokinase polymorphisms associated with maturity-onset diabetes of the young (MODY2) in Jordanian population.
Al-Sheyab F; Khamaiseh E; Halaweh MA; Khaul RW
Tsitol Genet; 2009; 43(5):58-63. PubMed ID: 20458967
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of MODY2 mutations highlights the importance of the fine-tuning of glucokinase and its role in glucose sensing.
García-Herrero CM; Rubio-Cabezas O; Azriel S; Gutierrez-Nogués A; Aragonés A; Vincent O; Campos-Barros A; Argente J; Navas MA
PLoS One; 2012; 7(1):e30518. PubMed ID: 22291974
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
Valentínová L; Beer NL; Staník J; Tribble ND; van de Bunt M; Hučková M; Barrett A; Klimeš I; Gašperíková D; Gloyn AL
PLoS One; 2012; 7(4):e34541. PubMed ID: 22493702
[TBL] [Abstract][Full Text] [Related]
12. Insight into the biochemical characteristics of a novel glucokinase gene mutation.
Shen Y; Cai M; Liang H; Wang H; Weng J
Hum Genet; 2011 Mar; 129(3):231-8. PubMed ID: 21104275
[TBL] [Abstract][Full Text] [Related]
13. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.
Beer NL; Tribble ND; McCulloch LJ; Roos C; Johnson PR; Orho-Melander M; Gloyn AL
Hum Mol Genet; 2009 Nov; 18(21):4081-8. PubMed ID: 19643913
[TBL] [Abstract][Full Text] [Related]
14. Glucokinase mutations in pediatric patients with impaired fasting glucose.
Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
[TBL] [Abstract][Full Text] [Related]
15. Functional Characterization of a Novel Heterozygous Mutation in the Glucokinase Gene That Causes MODY2 in Chinese Pedigrees.
Jiang F; Yan J; Zhang R; Ma X; Bao Y; Gu Y; Hu C
Front Endocrinol (Lausanne); 2021; 12():803992. PubMed ID: 34956103
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
[TBL] [Abstract][Full Text] [Related]
17. Glucokinase (GCK) mutations and their characterization in MODY2 children of southern Italy.
Capuano M; Garcia-Herrero CM; Tinto N; Carluccio C; Capobianco V; Coto I; Cola A; Iafusco D; Franzese A; Zagari A; Navas MA; Sacchetti L
PLoS One; 2012; 7(6):e38906. PubMed ID: 22761713
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY).
Toaima D; Näke A; Wendenburg J; Praedicow K; Rohayem J; Engel K; Galler A; Gahr M; Lee-Kirsch MA
Hum Mutat; 2005 May; 25(5):503-4. PubMed ID: 15841481
[TBL] [Abstract][Full Text] [Related]
19. Analysis of mutations in the glucokinase gene in people clinically characterized as MODY2 without a family history of diabetes.
Lopez AP; de Dios A; Chiesa I; Perez MS; Frechtel GD
Diabetes Res Clin Pract; 2016 Aug; 118():38-43. PubMed ID: 27289208
[TBL] [Abstract][Full Text] [Related]
20. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations.
Pruhova S; Dusatkova P; Sumnik Z; Kolouskova S; Pedersen O; Hansen T; Cinek O; Lebl J
Pediatr Diabetes; 2010 Dec; 11(8):529-35. PubMed ID: 20337973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
